Mary West

Ms. West, Vice President, Clinical Operations, brings an extensive background in complex clinical trial execution and team leadership. Most notably, she led all clinical operations at Boston-based Alnylam Pharmaceuticals for their lead product, Onpattro®, in a successful registration trial that recruited over 220 patients globally and led to the historic approval of the fist siRNA therapy in late 2018. Ms. West has previously served in clinical operations leadership roles at BlueRock Therapeutics, Skyhawk, Paratek, Momenta, Acambis, Millennium and Pfizer. Ms. West received her M.S. in project management from Boston University and her B.S. in dietetics from Michigan State University.